Omnipaque 240mg/mL PF, 300mg/mL PF, in 3 mL, 5 mL, and 10 mL, vials, manufactured by New England Compounding Center, Framingham, MA
Published January 9, 2013 · Recall initiated: September 26, 2012
Summary
FDA records drug Class II recall D-122-2013, published January 9, 2013 and initiated September 26, 2012. Recalling firm: New England Compounding Center; Status: Terminated; Reported quantity: 8919 vials; Lot: All lot codes. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- New England Compounding Center
- Distributor
- Nationwide
- Lot
- All lot codes
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAGlycerin 100% PF, 1mL, 2 mL, and 5 mL vials, manufactured by New England Compounding Center, Framingham, MAJanuary 9, 2013
- FDAMethylprednisolone Acetate 40 mg/mL Injection, Preserved, supplied in 5 mL and 10 mL vials, manufactured byJanuary 9, 2013
- FDAIsovue 200 mg/mL PF and 300 mg/mL PF, Vials, manufactured by New England Compounding Center, Framingham, MAJanuary 9, 2013
- FDAMethylprednisolone Acetate (PF) 40 mg/ml Injection, supplied in 1 mL, 2 mL and 5 mL vials, manufactured by NewJanuary 9, 2013
- FDALidocaine 1% PF, 2% PF, and 4% PF, in 1 mL, 2 mL, 5 mL, and 10 mL vials, manufactured by New EnglandJanuary 9, 2013
- FDASaline 10% and 3%, in 5 mL and 10 mL vials, manufactured by New England Compounding Center, Framingham, MAJanuary 9, 2013
Questions about this recall
Was Omnipaque 240mg/mL PF, 300mg/mL PF, in 3 mL, 5 mL, and 10 mL, vials, manufactured by New England Compounding Center, Framingham, MA recalled?
Yes. FDA published recall D-122-2013 on January 9, 2013. Reported hazard: Lack of Assurance of Sterility
What should I do if I have this product?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit